Trial Profile
To investigate weather the concentration of baseline serum cytokines can become the predictor of treatment response of tocilizimab.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- Acronyms PREDICT-TCZ
- 09 May 2013 New trial record